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Nanoparticle characterization 15
The mean hydrodynamic diameter and the polydispersity index (PDI) of the NPs were 16 determined by dynamic light scattering (DLS) using a Malvern Zetasizer ZS (Malverncontaining EDTA as anticoagulant were used for blood collection. Red blood cells were isolated 12 by centrifugation at 3,000 rpm for 10 min, and washed three times in an isotonic phosphate buffer 13 solution (PBS) containing 123.3 mM NaCl, 22.2 mM Na2HPO4 and 5.6 mM KH2PO4 in distilled 14 water (pH 7.4; 300 mOsmol/l). The cell pellets were then suspended in PBS at a cell density of 15 8 x 10 9 cell/ml. 16
Hemolysis assay 18
The pH-dependent membrane-lytic activity of the NPs was assessed using the hemolysis 19 assay, with the erythrocytes as model of the endosomal membrane [18, 24] . PBS buffers in the 20 pH range of 5.4 -7.4 were prepared to be isosmotic to the inside of the erythrocyte and cause 21 negligible hemolysis. The 25-μl aliquots of erythrocyte suspension were exposed to NPs at 22 concentrations up to 500 μg/ml (referred to total content in the NP dispersion) dissolved in PBS 23 solution in a total volume of 1 ml. Two controls were prepared by resuspending erythrocyte 24 suspension either in buffer alone (negative control) or in distilled water (positive control). Thesamples were incubated at room temperature under constant shaking for 10 or 60 min, and then 1 centrifuged at 10,000 rpm for 5 min. Supernatants were taken, the absorbance of the hemoglobin 2 release was measured at 540 nm using a double-beam Shimadzu UV-1800 UV-VIS 3 spectrophotometer (Shimadzu, Kyoto, Japan), and the percentages of hemolysis were determined 4 by comparison with the positive control samples totally hemolyzed with distilled water. 5 6
Cell culture 7
The murine Swiss albino 3T3 fibroblast cell line was grown in DMEM medium 8 supplemented with 10% (v/v) FBS, L-glutamine (584 mg/l) and antibiotic/antimicotic (50 mg/ml 9 gentamicin sulfate and 2 mg/l amphotericin B), at 37 °C, 5% CO2. The 3T3 cells were routinely 10 cultured in 75 cm 2 culture flasks and were trypsinized using trypsin-EDTA when the cells 11 reached approximately 80% confluence. 12 13
Cytotoxicity assays 14
The cytotoxic effect of the CS-based NPs containing the surfactants was measured by 15 tetrazolium salt MTT assay [25] and neutral red uptake (NRU) assay [26] . 3T3 cells were seeded 16 into the central 60 wells of a 96-well plate at a density of 1 x 10 5 cells/ml. After incubation for 17 24 h under 5% CO2 at 37 ºC, the spent medium was replaced with 100 µl of fresh medium 18 supplemented with 5% FBS containing NP dispersions at the required concentration range (25-19 300 μg/ml, referred to total content in the NP dispersion). After 24 h, the NP-containing medium 20 was removed, and 100 µl of MTT in PBS (5 mg/ml) diluted 1:10 in medium without FBS was 21 then added to the cells. Similarly, 100 µl of 50 μg/ml NR solution in DMEM without FBS was 22 added in each well for the NRU assay. The plates were further incubated for 3 h, after which the 23 medium was removed, and the wells of the NRU assay were washed once in PBS. Thereafter, 24 assay). Likewise, for the NRU assay 100 µl of a solution containing 50% ethanol absolute and 1 1% acetic acid in distilled water was added to extract the dye. After 10 min shaking at room 2 temperature, the absorbance of the resulting solutions was measured at 550 nm using a 3 SpectraMax M2 (Molecular Devices, Sunnyvale, CA, USA) microplate reader. The effect of each 4 treatment was calculated as a percentage of cell viability inhibition against the respective 5 controls. 6 7
Statistical analysis 8
Each hemolysis and cytotoxicity experiment was performed at least three times using 9 three replicate samples for each NP concentration tested. Results are expressed as mean ± 10 standard error of the mean (SE). Statistical analyses were performed using one-way analysis of 11 variance (ANOVA) to determine the difference between the sets of data, followed by Tukey's 12 posthoc test for multiple comparisons, using the SPSS ® software (SPSS Inc., Chicago, IL, USA). 13 p < 0.05 was considered statistically significant, and p < 0.005 were considered highly 14 statistically significant. CS undergoes ionotropic gelation and precipitates to form spherical particles that are 1 distinguishable by opalescence of solution. The size of NPs could be controlled especially by 2 modifying the molecular weight of CS and, in a lesser extent, by changing the CS-to-TPP ratios 3 ( Table 2 ). Noteworthy that besides its influence on the NP size, the polymer weight ratio (w/w) 4 can affect the biological performance of CS-NPs, as demonstrated in the next sections of this 5 paper. Our results demonstrated that the size distribution for CS-NPs with LMW-CS were 6 smaller (~168 nm) than that for NPs prepared with MMW-CS (~310 nm). Likewise, we observed 7 that with increasing amount of the counterion TPP, scattering intensity increases with the 8 accompanying decrease in particle size. The formulations CS-NP03 and CS-NP04, with CS:TPP 9 ratio of 5:1, have a slight opalescence and a larger mean diameter (162.9 and 183 nm, 10 respectively). On the other hand, CS-NP05 and CS-NP06 showed a medium opalescence and a 11 smaller size (156.9 and 170.4 nm, respectively), which might be attributed to the higher quantity 12 of the polyanion TPP (ratio CS:TPP of 5:2). These results are in agreement with the work 13 reported by Gan et al. [21] , in which it was demonstrated a linear decrease of size with decreasing 14 CS to TPP weight ratio. However, it is worth pointing out that the addition of excess polyanion 15 neutralized all the positive charges of CS, which in turn resulted in the loss of potential cross-16 linking sites and in NP flocculation. Low to moderate CS to TPP weight ratio is necessary to 17 achieve stable and size-controlled NPs. Finally, it is worth pointing out that the NPs incorporating 18 77KL or 77KS exhibited increased mean diameter. Additional dimensions of 36.9, 20.1 and 13.5 19 nm were observed for CS-NP02, CS-NP04 and CS-NP06, respectively, in relation to those 20 formulations without surfactants. 21
All CS-NPs exhibited a positive surface charge around + 25 to + 30 mV (Table 2) In order to gain insight into the morphology of NPs, TEM analysis of the formulations 14 CS-NP01 and CS-NP02 were performed (Fig. 1) . As the composition of the NPs is rather similar, 15
we chose only two formulations in order to compare whether the presence of the surfactant affects 16 or not the NP morphology. The results showed that both NP suspensions dispersed in watershowed clearly mono-dispersed particles, and had a regular and roughly spherical shape, 1 independently on the presence of surfactant. It is noteworthy that TEM images revealed NPs 2 much smaller (40 -80 nm) than the hydrodynamic diameters measured by DLS. This discrepancy 3 in the NP size between DLS and TEM can be attributed to the fact that NPs swell in aqueous 4 medium and DLS gives the size of the particle surrounded by the solvation layers, while TEM 5
gives the diameter of particles alone in the dry state [29, 32] . Additionally, the divergence 6 between nanosizes may also be related to surface used for TEM analysis, which does not allow 7 the particles to agglomerate, but let them separated. 
pH-dependent membrane-lytic activity 14
Hemolysis assay was performed to evaluate the pH-sensitive membranolytic activity and 15 predict the endosomolytic capability of CS-NPs. Erythrocytes are considered a simple model of 16 the endosomal membrane [18, 33] and, therefore, have been used as a convenient cell membrane 17 system to study NP-membrane interactions as a function of pH [7, 34, 35] . Moreover, they havecompartments have a pH from 6.5 to 6.8, while the lumen of late endosomes has a lower pH, of 1 about 5.5 [37, 38] . Therefore, we explored the membrane-lytic activity of the NPs at the pH range 2 of 5.4 to 7.4, mimicking the environment that these nanocarriers are expected to encounter when 3 translocating through the endocytic pathway. 4 Fig. 2 shows the membrane-lytic activity of the NPs incorporating or not a surfactant as 5 a function of pH, with varying concentration and incubation time. At low concentrations, the NPs 6 incorporating either of the surfactants showed low or negligible hemolytic activity at pH 7.4. 7
When pH decreased to 6.6, CS-NP02 and CS-NP04 had increased membrane-lytic capability and 8 so did CS-NP06, but to a lesser extent, resulting in a maximum hemolysis of 61.23, 77.46 and 9 24.73%, respectively. At pH 5.4, all NPs with 77KS or 77KL showed stronger membrane-lytic 10 activity (p < 0.005), reaching maximum of about 87% hemolysis. On the other hand, all 11 formulations without the surfactants showed no pH-sensitive activity throughout the endosomal 12 pH range and, thus, do not seen to have any ability to facilitate endosomal destabilization. 13
Altogether, these results confirmed that the improved membrane-lytic behavior of NPs at acidic 14 environment is due to the presence of surfactants. To better visualize the pH-dependent membranolytic activity of the NPs, graphics were 8 constructed expressing the hemolysis rate of each formulation as a function of pH (Fig. 3) . The 9 pK50, which means the pH at which 50% hemolysis is obtained, was calculated for the 10 formulations containing the surfactant 77KS or 77KL. This value was estimated from the pH-11 response curves showed in Fig. 3b [39] . The pK50 values found for CS-NP02, CS-NP04 and CS-12 NP06 were 6.78, 7.04 and 5.84, respectively. From these results we can observe that the 13 formulation with higher amount of TPP (CS-NP06) displayed a hemolysis response curve shifted 14 toward lower pH, while the other two NPs, with lower concentration ratio of TPP, showed a 15 higher sensitivity to a small variation of pH. This might be attributed to a lower incorporation of 16 the surfactant 77KS into the NP structure when greater amount of TPP is present. It seems that 17 there is a bigger competition between 77KS and TPP for the positive sites of CS in CS-NP06. 18
Therefore, these results support the early lytic activity of CS-NP02 and CS-NP04 at the pH range 19 of early endosomal compartments (pH 6.6), whereas CS-NP06 induced considerable lysis only 20 at the pH characteristic of late endosomes (pH 5.4). Despite the individual differences within the pH range tested, all NPs displayed hemolytic 7 activity dependent on the concentration. Here, this enhanced membrane-lytic activity with 8 increasing NP concentration could be due to the stronger affinity of positively charged NPs 9 towards the negatively charged cell membrane [40] . Furthermore, the positive charge of the NPs 1 is expected to facilitate their cellular transport and adhesion [41] . 2
As the pH-responsive activity of NPs was clearly demonstrated to be dependent on the 3 presence of 77KS or 77KL, it can be inferred that the most significant hemolysis at acidic 4 environments must be due to a modification in the hydrophobic/hydrophilic balance of these 5 compounds at the acidic pH range. Noteworthy is the enhanced membrane lysis at pH 6.6 and 6 5.4 independently on the surfactant counterion. Therefore, it was assumed that the carboxylic 7 group of the amino acid lysine undergoes an increase in its pKa value (reported to be originally 8 of the order of 2.2) when it is included in the surfactant molecule. In order to confirm this 9 hypothesis, we determined the pKa of 77KL and found that it is 6.2. Therefore, the enhanced 10 hemolysis induced by NPs incorporating the pH-responsive surfactants might be due to the 11 increasing protonation state of their carboxylic group at the acidic endosomal pH range. The 12 protonation of the surfactant molecule makes it non-ionic and enhanced its hydrophobicity, 13 which would increase binding to the membrane and, therefore, its lysis. This mechanism 14 described for the behavior of the surfactants at acidic conditions, together with the fact that the 
Kinetics of pH-dependent membrane-lytic activity 20
Considering that the formulations without surfactant did not displayed a pH-sensitive 21 activity throughout the endosomal pH range, the kinetics of pH-dependent membrane-lytic 22 activity was evaluated especially for NPs incorporating a surfactant. The results are also shown 23 in Fig. 2 .
Negligible membrane lysis was induced by all NPs with 77KS or 77KL after 10 min 1 incubation at physiological pH, while 60 min incubation prompted a slight increased hemolysis 2 rate (between 10 and 27% hemolysis). It is noteworthy that when the same NPs were formulated 3 without surfactants, a lesser extent of hemolysis was observed (between 3 and 15% hemolysis). 4
These results demonstrated that the higher hemolytic activity of the first formulations is due to 5 the presence of surfactant. It is well known that amphiphilic substances usually have some 6 unspecific interactions with lipid bilayer, leading to membrane lysis [42] . Between 77KS and 7 77KL, it is possible to notice that CS-NP04, incorporating 77KS, were more hemolytic than CS-8 NP02, incorporating 77KL. Both NPs have the same CS:TPP ratio and the given results may be 9 related to the higher membrane-lytic activity of 77KS itself, as demonstrated in our previous 10 report [13] . At pH 7.4, 77KS has a HC50 (concentration inducing 50% hemolysis) of 298.90 11 μg/ml, while for 77KL the value is 489.22 μg/ml. Likewise, the greater hemolysis could be 12 attributed to the smaller size of the NPs incorporating 77KS, which might facilitate their insertion 13 into the lipid bilayer of the plasma membrane and, thus, it lysis. 14 As the pH decrease to 6.6 or 5.4, the membrane-lytic activity of the NPs incorporating 15 conditions assessed, confirming their inability to disrupt endosomal membranes. Noteworthy is 2 the rather unexpected kinetics of hemolytic activity presented by CS-NP03. However, this 3 activity is significantly lower than that observed for the same formulation incorporating 77KS 4 (CS-NP04). 5
The significant hemolytic kinetics at acidic conditions shown by NPs incorporating 77KS 6 or 77KL indicates that a previous step seem to be required before the erythrocyte membrane 7 becomes permeable to hemoglobin, i.e. the formation of pores or channels that lead to the efflux 8 of low molecular weight solutes. It is worth mentioning that the molecules taken up by 9 endocytosis are trafficked from early endosomes to lysosomes within several hours [43] . Thus, 10 timely permeabilization of the endosomal membrane is a prerequisite for cytosolic translocation 11 of drugs in order to exert their pharmacological effect [44] . Therefore, given the improved 12 hemolytic kinetics and pH-responsive membrane activity of CS-NP02, CS-NP04 and CS-NP06, 13 these formulations might have the ability to disrupt endosomal membranes before fusion of the 14 endocytic vesicles with lysosomes, thus avoiding non-productive intracellular trafficking, a 15 critical feature for potential intracellular drug delivery applications. 16 17
Cytotoxicity studies 18
The cytotoxicity of the NPs was assessed using in vitro cell-based assays with 3T3 19 fibroblasts as cell model, and MTT and NRU as endpoints to determine the cell viability. We 20 evaluated the cytotoxicity of the NPs containing 77KS or 77KL, as the occurrence of any 21 damaging effects is expected to be due the presence of surfactants. Noteworthy that our previous 22 study on the cytotoxicity of these surfactants revealed their low cytotoxic effects against different 23 cell lines in comparison to the typical commercial surfactant sodium dodecyl sulfate (SDS) [14] .cytotoxicity of the surfactant 77KL was lower than that of 77KS. However, from these results, it 11 can be inferred that the complexation of the surfactants into the polymeric NPs changed their 12 cytotoxic profiles. 13
Despite the presence of a surfactant as a bioactive compound into the formulations, it was 14 showed that the proposed nanocarriers displayed general low or negligible cellular toxicity and, 15 thus, can be suitable intracellular drug delivery systems without nonspecific cytotoxicity. The 16 biocompatible properties and natural source of these surfactants clear collaborate for the 17 biocompatibility of the designed NPs. (from left to right) of 250 μg/ml (blank), 125 μg/ml (striped), 50 μg/ml (black) and 25 μg/ml 4 (gray). The data represent the mean of three independent experiments ± SE (error bars). 5 weight ratio and type of the surfactant counterion. It was clearly demonstrated that the NPs 1 containing the lysine-based surfactants have membranolytic activity specifically in mildly acidic 2 conditions found in the endosomal compartments. Moreover, the improved kinetics of the 3 hemolytic activity supports the ability of these functional nanodevices to disrupt endosomal 4 membranes before vesicular evolution from endosomes to lysosomes, where many drugs may 5 suffer degradation. Altogether, the results suggested the potential capability of these pH-6 responsive nanocarriers to promote an improved delivery of bioactive compounds to the 7 intracellular compartments. This hypothesis is partially proven by a membrane lysis study on 8 human erythrocyte. However, further in vitro and in vivo studies should be performed to improve 9 the knowledge underlying this process. 10
